Pneumocystis jirovecii Infection | ClinicalTrials HQ

View definition

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia	Bacterial Infections and Mycoses, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, Respiration Disorders, Respiratory Aspiration, fungal infectious disease, fungal lung infectious disease, interstitial lung disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Recruiting	Phase 1 / Phase 2	2026-10-09		NCT06892951
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia	Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Recruiting	Phase 3	2026-02-20		NCT04851015
Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)	Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Not yet recruiting	Phase 4	2026-01-21		NCT07357103
How Long Should we Give Steroids for Patients With Severe PCP	Bacterial Infections and Mycoses, Infections, Pneumocystis infectious disease, Pneumocystis jirovecii Infection, fungal infectious disease, fungal lung infectious disease, lung disorder, pneumocystosis, pneumonia, respiratory system disorder, respiratory tract infectious disorder	Not yet recruiting	Phase 4	2026-01-09		NCT07328984